NCT03640481 2024-12-12Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapySanofiPhase 2 Terminated159 enrolled 25 charts 2 FDA
NCT05382377 2022-05-19NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid TumorsThe Affiliated Hospital of the Chinese Academy of Military Medical SciencesPhase EARLY_PHASE1 Recruiting18 enrolled